Anticoag Evaluator

The American College of Cardiology’s AnticoagEvaluator is an easy and fast way to assess stroke and bleeding risk and the benefits and risks of antithrombotic therapy in patients with chronic atrial fibrillation.

Features:

• A combination risk calculator tool that uses CHADS2, CHA2DS2-VASc, and HAS-BLED

• Users can enter patient characteristics at the point of care and get individualized annual risk of ischemic stroke and thromboembolism with concurrent annual risk of major bleed

• Compare antithrombotic therapy options based on clinical trials (ACTIVE-A, RE-LY, ROCKET-AF, ARISTOTLE)

This app is adapted from a web tool created by Peter Loewen, B.Sc.(Pharm), ACPR, Pharm.D., FCSHP and can be viewed at http://www.sparctool.com/